Royal Bank of Canada
IMMU

Royal Bank of Canada’s Immunomedics Inc IMMU Stock Holding History

Royal Bank of Canada’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,500
Closed -$21K – 7366
2019
Q2 		$21K Sell
1,500
-300
-17% -$4.51K ﹤0.01% 5705
2019
Q1 		$35K Sell
1,800
-1,200
-40% -$19.3K ﹤0.01% 5373
2018
Q4 		$43K Buy
+3,000
New +$59.6K ﹤0.01% 5180

Royal Bank of Canada's IMMU Position: Q4 2020 in Review

Royal Bank of Canada sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 220,582 shares — an estimated $18.8M sold.

Royal Bank of Canada first reported a position in IMMU in Q2 2013 and held it in 28 quarters. The position peaked at $18.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Royal Bank of Canada reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Royal Bank of Canada sold 220,582 Immunomedics Inc shares in Q4 2020, an estimated $18.8M.
  • Royal Bank of Canada first reported a position in Immunomedics Inc in Q2 2013 and held it in 28 quarters.
  • Royal Bank of Canada's Immunomedics Inc position peaked at $18.8M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Royal Bank of Canada's 13F filing for Q4 2020, filed 16 Feb 2021.